Helping to close the loop on glycaemic control
A patient’s experience of evolving technology for type 1 diabetes management highlights the gains such devices can help achieve in control and quality of life
Kaye is a 60-year-old woman with a highly demanding job as a CEO.
She was diagnosed with type 1 diabetes at age 54 and started on basal insulin glargine and bolus insulin aspart.
